Bliss GVS Pharma Limited has informed the Exchange regarding 'Notice to Shareholders w.r.t. transfer of unclaimed Final Dividend 2017-2018 and itsCorresponding Shares to Investor Education and Protection Fund (IEPF) Authority'.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the exchanges that it has sent notices to shareholders whose dividends have remained unclaimed for seven or more consecutive years. Under Section 124(6) of the Companies Act, 2013, the corresponding equity shares of such shareholders will be transferred to the Investor Education and Protection Fund (IEPF) Authority. The transfer covers shareholders who did not claim the final dividend declared on August 24, 2018 (FY2017-18) and all subsequent unpaid dividends up to FY2023-24. The shares will be moved to IEPF on or after September 30, 2025. The final dividend for FY2016-17 has already been transferred earlier. Affected shareholders can prevent the transfer by submitting KYC and claim documents to the Registrar (MUFG Intime India) before September 30, 2025.
This is a routine regulatory compliance filing under SEBI LODR Regulations and the Companies Act, with no material impact on the company's financials, operations, or share price. Shareholders who have not encashed their FY2017-18 onwards dividends must act before September 30, 2025 to recover their shares; after that date they can only reclaim shares from IEPF by filing e-form IEPF-5.